Testing the NeuroCytotron device for autism spectrum disorder
Part of Mental health clinical trials.
This trial tests a device called the NeuroCytotron to see if it can help people with autism. It is for individuals aged 3 to 50 who have a confirmed autism diagnosis and are medically stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed autism diagnosis based on standard criteria (DSM-5).
- You must be between 3 and 50 years old.
- Your autism severity is mild to severe (grades 1 to 3).
- You must be willing and able to attend treatment sessions and give consent (or have a parent/guardian do so).
- You cannot have uncontrolled epilepsy or other serious medical issues that might make the device unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new brain stimulation therapy (called NeuroCytotron) to see if it helps children with autism who have some verbal communication. The goal is to help the brain form new connections and improve symptoms.
This study tests a computerized “cognitive remediation” program adapted for people with autism, using social scenarios and skills. The goal is to improve thinking and related day-to-day abilities by practicing structured tasks on a screen.
This trial tests whether a safe, non-invasive brain stimulation treatment (called rTMS) is well-tolerated in children and teens with autism. rTMS uses magnetic pulses to gently stimulate parts of the brain, and this study wants to see if it can be given safely to young people with autism.
This study tests a non-invasive brain stimulation technique called transcranial temporal interference stimulation (a safe electrical method applied to the scalp) to help improve symptoms in children with autism spectrum disorder (ASD). The goal is to see if this treatment can help with social communication, behavior, and other autism-related challenges.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This trial tests if mild electrical stimulation applied to the head (tDCS) can help children with autism. Your child must be enrolled in ABA therapy and be off certain medications to join.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.